1. Wattana M, Bey T. Mustard gas or sulfur mustard: an old chemical agent as a new terrorist threat. Prehosp & Disast Med. 2009; 24(1): 19-29.
2. Kehe K, Szinicz L. Medical aspects of sulphur mustard poisoning. Toxicol. 2005; 214(3): 198-209.
3. Khateri S, Ghanei M, Keshavarz S, Soroush M, et al. Incidence of lung, eye, and skin lesions as late complications in 34,000 Iranians with wartime exposure to mustard agent. Occup & Environ J Med. 2003; 45(11): 1136-43.
4. Korkmaz A, Yaren H, Topal T, Oter S. Molecular targets against mustard toxicity: implication of cell surface receptors, peroxynitrite production, and PARP activation. Arch of Toxicol. 2006; 80(10): 662-70.
5. Borak J, Sidell FR. Agents of chemical warfare: sulfur mustard. Ann of Emerg Med. 1992; 21(3): 303-8.
6. Asai K, Kanazawa H, Kamoi H, Shiraishi S, et al. Increased levels of vascular endothelial growth factor in induced sputum in asthmatic patients. Clin & Exp Allergy. 2003; 33(5): 595-9.
7. Gilasi H, Holakouie Naieni K, Zafarghandi M, Mahmoudi M, et al. Relationship between mustard gas and cancer in Iranian soldiers of imposed war in Isfahan Province: A Pilot Study. J of Sch of Public Health and Inst of Public Health Res. 2006; 4(3): 15-23.
8. Emadi N, Soroush M, Moinoldin F, Davoudi S, et al. Atrophy and poikiloderma after skin contact with mustard gas: a case report. IR J Dermatol. 2007; 10(42): 345-52.
9. Davoudi M, Shohrati M, Sadr B. Prevalence of skin tumors in chemically Iranian veterans in 17 province compared with the normal population. J Army Univ Med Sci IR. 2006; 4(1): 751-4.
10. Karimi Zarchi A, Holakoie Naieni K. Long term pulmonary complications in Iranian veterans exposed to sulfur mustard: a historical cohort study. J Sch Public Health Inst Public Health Res. 2002; 1(4): 15-22.
11. Agin Kh, Ghasemi Broumand M. Epidemiological relationship with late complications of sulfur mustard gas on 500 Iranian chemically injured after 15 years. J Army Univ Med Sci IR. 2004; 2(1): 269-73.
12. Ghasemi Broumand M, Agin Kh, Amiri Z. Late ocular and pulmonary complications in chemically injured veterans with mustard gas referred to Institute of Medicine committees in 2001. Bina J Ophthalmol. 2003; 9(2): 165-71.
13. Montani JP, Vliet VB. General physiology and pathophysiology of the renin-angiotensin system. Angiotensin Vol. I: Springer; 2004: 3-29.
14. Hosseini khalili AR, Thompson J, Kehoe A, Hopkinson NS, et al. Angiotensin-converting enzyme genotype and late respiratory complications of mustard gas exposure. BMC Pulm Med. 2008; 8(1):15.
15. Crisan D, Carr J. Angiotensin I-converting enzyme: genotype and disease associations. J of Mol Diagn. 2000; 2(3): 105.
16. Sayed Tabatabaei F, Oostra B, Isaacs A, Van Duijn C, et al. ACE polymorphisms. Circ Res. 2006; 98(9): 1123-33.
17. Rigat B, Hubert C, Alhenc Gelas F, Cambien F, et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J of Clin Investig. 1990; 86(4): 1343.
18. Harding D, Baines PB, Brull D, Vassilion V, et al. Severity of meningococcal disease in children and the angiotensin-converting enzyme insertion/deletion polymorphism. Am J of Respir & Crit Care Med. 2002; 165(8): 1103-6.
19. Harding D, Dhamrait S, Marlow N, Whitelaw A, et al. Angiotensin-converting enzyme DD genotype is associated with worse perinatal cardiorespiratory adaptation in preterm infants. J of Pediatr. 2003; 143(6): 746-9.
20. Hopkinson NS, Nickol AH, Payne J, Hawe E, et al. Angiotensin converting enzyme genotype and strength in chronic obstructive pulmonary disease. Am J of Res & Crit Care Med. 2004; 170(4): 395-9.
21. Reneland R, Lithell H. Angiotensin-converting enzyme in human skeletal muscle. A simple in vitro assay of activity in needle biopsy specimens. Scand J of Clin & Lab Investig. 1994; 54(2): 105-11.
22. Reneland R, Haenni A, Andersson PE, AndrEn B, et al. Skeletal muscle angiotensin-converting enzyme and its relationship to blood pressure in primary hypertension and healthy elderly men. Blood Press. 1999; 8(1): 16-22.
23. Brull D, Sanders J, Rumley A, Lowe G, et al. Impact of angiotensin converting enzyme inhibition on post-coronary artery bypass interleukin 6 release. Heart. 2002; 87(3): 252-5.
24. Elferink JG, Koster BM. The stimulation of human neutrophil migration by angiotensin II: its dependence on Ca2+ and the involvement of cyclic GMP. Br J of Pharmacol. 1997; 121(4): 643-8.
25. Kranzhofer R, Browatzki M, Schmidt J, Kubler W. Angiotensin II activates the proinflammatory transcription factor nuclear factor-κB in human monocytes. Biochem & Biophys Res commun. 1999; 257(3): 826-8.
26. Pueyo ME, Gonzalez W, Nicoletti A, Savoie F, et al. Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-κB activation induced by intracellular oxidative stress. Arteriosclerosis, Thromb, & Vasc Biol. 2000; 20(3): 645-51.
27. Zakheim R, Mattioli L, Molteni A, Mullis K, et al. Prevention of pulmonary vascular changes of chronic alveolar hypoxia by inhibition of angiotensin I-converting enzyme in the rat. J of Tech Methods & Pathol. 1975; 33(1): 57-61.
28. Munhoz TP, Scheibe RM, Schmitt VM. Angiotensin converting enzyme (ACE) DD genotype: relationship with venous thrombosis. Rev Bras Hematol Hemoter. 2005; 27(2): 87-90.
29. Fekri A. Late cutaneous complications in chemical warfare victims in Kerman province. J of Kerman Univ of Med Sci. 1995; 2(3): 108-19.
30. Ghassemi Broumand M, Aslani J, Emadi SN. Delayed ocular, pulmonary, and cutaneous complications of mustards in patients in the city of Sardasht, Iran. Cutan & Ocul Toxicol. 2008; 27(4): 295-305.
31. Rezvani SM, Mahmoodipour A. Complications and symptoms of skin in chemically injured war (dermatology clinic of Yahyanejad Babol 1380-1382). Babol Univ Med Sci. 2003; 8(2): 74-82.
32. Emadi SN, Mortazavi M, Mortazavi H. Late cutaneous manifestations 14 to 20 years after wartime exposure to sulfur mustard gas: a long-term investigation. Arch of Dermatol. 2008; 144(8): 1059-61.
33. Pechura C.M, Rall D.P. Veterans at risk: the health effects of mustard gas and lewisite. National Academies. (eds); 1993.
34. Easton D, Peto J, Doll R. Cancers of the respiratory tract in mustard gas workers. Br J of Ind Med. 1988; 45(10): 652-9.
35. Balali Mood M, Hefazi M. A review on the delayed complications of sulphur mustard poisoning. J of Birjand Univ of Med Sci. 2006; 12(3&4).
36. Vidan A, Luria S, Eisenkraft A, Hourvitz A. Ocular injuries following sulfur mustard exposure: clinical characteristics and treatment.Isr Med Assoc J. 2002; 4(7): 577-8.
37. Marshall RP, Webb S, Bellingan GJ, Montgomery HE, et al. Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome. Am J of Res & Crit Care Med. 2002; 166(5): 646-50.
38. Onizuka M, Kasai M, Oba T, Atsuta Y, et al. Increased frequency of the angiotensin-converting enzyme gene D-allele is associated with noninfectious pulmonary dysfunction following allogeneic stem cell transplant. Bone Marrow Transpl. 2005; 36(7): 617-20.
39. Emad A, Rezaian GR. The Diversity of the Effects of Sulfur Mustard Gas Inhalation on Respiratory System 10 Years After a Single, Heavy Exposure Analysis of 197 Cases. Chest J. 1997; 112(3): 734-8.
40. Gao J, Lin Y, Xiao Y, Xu K, et al. Polymorphism of angiotensin-converting enzyme gene and genetic susceptibility to asthma with familial aggregation. Chin Med Sci J= Chung-kuo i hsueh k'o hsueh tsa chih/Chin Acad of Med Sci. 2000; 15(1): 24-8.
41. Lue KH, Ku MS, Li C, Sun HL, et al. ACE gene polymorphism might disclose why some Taiwanese children with allergic rhinitis develop asthma symptoms but others do not. Pediatr Allergy & Immunol. 2006; 17(7): 508-13.
42. Kazzi SNJ, Quasney MW. Deletion allele of angiotensin-converting enzyme is associated with increased risk and severity of bronchopulmonary dysplasia. J of Pediatr. 2005; 147(6): 818-22.
43. Lee JM, Lo AC, Yang SY, Tsau HS, et al. Association of angiotensin-converting enzyme insertion/deletion polymorphism with serum level and development of pulmonary complications following esophagectomy. Ann of surg. 2005; 241(4): 659.